Evidence Hub

Determination of Embryotoxic Effects of Levofloxacin Exposure by the In Ovo Method

Rahmi Canbar, Osman Dağar, Tuğba Melike Parlak, Mehmet Tuzcu, Enver Yazar

Eurasian journal of veterinary sciences, 2026

30 participants

Abstract

Levofloxacin is a broad-spectrum antibacterial drug in the fluoroquinolone classthat is classified as category C during pregnancy. This study aimed to determine theeffects of levofloxacin administration on embryos at different developmental stages.It examined 420 fertile chicken eggs, divided into two main groups—levofloxacintreatment on days 7 and 14—each containing seven subgroups (n = 30 each): negativecontrol (no treatment), positive control (treated with saline), and five levofloxacindoses (5000, 2500, 1250, 625, and 312.5 μg/kg). On day 21, all eggs were hatched,the live–dead ratio was determined, and liver and kidney tissues were collected forhistopathological analysis. Administering levofloxacin to embryos at 7 and 14 days ofincubation had no lethal effect at doses up to 5000 μg/kg (p>0.05). Histopathologicalevaluations revealed no significant or clinically meaningful histopathologicaltoxicity was observed of levofloxacin on liver and kidney development (p>0.05). Inconclusion, when administered directly, levofloxacin does not have adverse effectson embryos at different developmental stages.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free